Search results for """ "Preparing for Disease X""

Book Synopsis

Read more less

Book SynopsisThe Balmis Expedition from Spain to the New World in 1806, launched off the heels of Jenner''s publication on vaccinia vaccine a few years previously, was likely the world''s first eradication initiative. The mission was to eradicate the deadly smallpox from the Americas and beyond. That goal, over a century and half later conceptualized and implemented under the guidance of the World Health Organization (WHO), was eventually realized. The core content of this textbook is designed to reflect the teaching elements of an intensive, one-week eradication course given first to graduate students at the School of Public Health, Johns Hopkins University (JHU) in Baltimore, United States, during the summer of 2012. The faculty of four consisted of the two editors of this textbook; Dr. Ciro de Quadros, former smallpox eradicator in Ethiopia and architect of the original polio eradication strategies; and Dr. D.A. Henderson, former head of the global smallpox eradication initiative, WHO. All four of us spent a full week together lecturing and mentoring JHU graduate students. In 2014, under the direction of Dr. Breman, the course was expanded and provided to graduate students at the Milken Institute School of Public Health, George Washington University. The materials in this textbook reflect the discussions in that course, especially with regards to what the co-editors believe to be the most practical, field relevant experiences and definitions. Given the rapidly changing medical and development world, this textbook highlights essential issues for success, illustrated by disease-specific case studies.

Read more less

Book Synopsis

Read more less

Book SynopsisThe objective of the first chapter is to explain fertility preservation decisions as related to reproductive-aged cancer patients experiences and desires for future fertility. The second chapter discusses fertility preservation and how it can be used to help cancer patients retain their fertility. It is an emerging discipline that now plays a central role in the care of reproductive women with cancer. This chapter examines several key factors underlying why more men who have sex with other men are not using Pre-Exposure Prophylaxis, including (1) lack of awareness of Pre-Exposure Prophylaxis, (2) lack of exposure to other Pre-Exposure Prophylaxis users, (3) general lack of interest in learning more about Pre-Exposure Prophylaxis, (4) lack of willingness to avail themselves of existing information sources and resources to learn more about Pre-Exposure Prophylaxis, (5) perceived stigma associated with the use of Pre-Exposure Prophylaxis, and (6) perceived obstacles needing to be overcome in order to give Pre-Exposure Prophylaxis adoption more serious consideration. The aims of this chapter is to describe some of these recent studies, showing the potential of the flavonoids anthocyanins, flavones, quercetin, hesperetin and naringenin in the control of adipocyte inflammation. The possible biochemical pathways will be presented, as well as the results observed in in vitro and in vivo studies. Chapter five explains how plasma transthyretin measures the methionine role in metabolic processes that requires deregulating the transsulfuration pathway and methylating homocysteine. It measures nutritional wellbeing and the impact of metabolism on the outcomes of human disease in relationship to severe inflammatory disorders, chronic disease, and cancer. The final chapter examines chronic kidney disease and how it is a significant burden on the economy and healthcare system globally as the patients suffering from it requires long term renal replacement therapy in the form of dialysis or renal transplant.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisA systematic review of the most current decision models and techniques for disease prevention and treatment Decision Analytics and Optimization in Disease Prevention and Treatmentoffers a comprehensive resource of the most current decision models and techniques for disease prevention and treatment.With contributions from leading experts in the field, this important resource presents information on the optimization of chronic disease prevention, infectious disease control and prevention, and disease treatment and treatment technology. Designed to be accessible, in each chapter the text presents one decision problem with the related methodology to showcase the vast applicability of operations research tools and techniques in advancing medical decision making. This vital resource features the most recent and effective approaches to the quickly growing field of healthcare decision analytics, which involves cost-effectiveness analysis, stochastic modeling, and computer simulation. ThrougTable of ContentsCONTRIBUTORS xiii PREFACE xvii PART 1 INFECTIOUS DISEASE CONTROL AND MANAGEMENT 1 1 Optimization in Infectious Disease Control and Prevention: Tuberculosis Modeling Using Microsimulation 3Sze-chuan Suen 1.1 Tuberculosis Epidemiology and Background 4 1.1.1 TB in India 5 1.2 Microsimulations for Disease Control 6 1.3 A Microsimulation for Tuberculosis Control in India 8 1.3.1 Population Dynamics 9 1.3.2 Dynamics of TB in India 9 1.3.3 Activation 10 1.3.4 TB Treatment 11 1.3.5 Probability Conversions 13 1.3.6 Calibration and Validation 14 1.3.7 Intervention Policies and Analysis 16 1.3.8 Time Horizons and Discounting 18 1.3.9 Incremental Cost-Effectiveness Ratios and Net Monetary Benefits 19 1.3.10 Sensitivity Analysis 22 1.4 Conclusion 22 References 23 2 Saving Lives with Operations Research: Models to Improve HIV Resource Allocation 25Sabina S. Alistar and Margaret L. Brandeau 2.1 Introduction 25 2.1.1 Background 25 2.1.2 Modeling Approaches 27 2.1.3 Chapter Overview 31 2.2 HIV Resource Allocation: Theoretical Analyses 31 2.2.1 Defining the Resource Allocation Problem 31 2.2.2 Production Functions for Prevention and Treatment Programs 35 2.2.3 Allocating Resources among Prevention and Treatment Programs 37 2.3 HIV Resource Allocation: Portfolio Analyses 39 2.3.1 Portfolio Analysis 39 2.3.2 O piate Substitution Therapy and ART in Ukraine 40 2.3.3 Pre-exposure Prophylaxis and ART 42 2.4 HIV Resource Allocation: A Tool for Decision Makers 44 2.4.1 REACH Model Overview 44 2.4.2 Example Analysis: Brazil 45 2.4.3 Example Analysis: Thailand 48 2.5 Discussion and Further Research 50 Acknowledgment 53 References 53 3 Adaptive Decision-Making During Epidemics 59Reza Yaesoubi and Ted Cohen 3.1 Introduction 59 3.2 Problem Formulation 61 3.3 Methods 63 3.3.1 The 1918 Influenza Pandemic in San Francisco, CA 63 3.3.2 Stochastic Transmission Dynamic Models 64 3.3.3 Calibration 66 3.3.4 O ptimizing Dynamic Health Policies 69 3.4 Numerical Results 73 3.5 Conclusion 75 Acknowledgments 76 References 76 4 Assessing Register-Based Chlamydia Infection Screening Strategies: A Cost-Effectiveness Analysis on Screening Start/End Age and Frequency 81Yu Teng, Nan Kong, and Wanzhu Tu 4.1 Introduction 81 4.2 Background Literature Review 83 4.2.1 Clinical Background on CT Infection and Control 83 4.2.2 CT Screening Programs 85 4.2.3 Computational Modeling on CT Transmission and Control 85 4.3 Mathematical Modeling 89 4.3.1 An Age-Structured Compartmental Model 89 4.3.2 Model Parameterization and Validation 93 4.4 Strategy Assessment 98 4.4.1 Base-Case Assessment 98 4.4.2 Sensitivity Analysis 100 4.5 Conclusions and Future Research 101 References 102 5 Optimal Selection of Assays for Detecting Infectious Agents in Donated Blood 109Ebru K. Bish, Hadi El-Amine, Douglas R. Bish, Susan L. Stramer, and Anthony D. Slonim 5.1 Introduction and Challenges 109 5.1.1 Introduction 109 5.1.2 The Challenges 111 5.2 The Notation and Decision Problem 113 5.2.1 Notation 114 5.2.2 Measures of Interest 115 5.2.3 Model Formulation 117 5.2.4 Relationship of the Proposed Mathematical Models to Cost-Effectiveness Analysis 118 5.3 The Case Study of the Sub-Saharan Africa Region and the United States 119 5.3.1 Uncertainty in Prevalence Rates 122 5.4 Contributions and Future Research Directions 123 Acknowledgments 123 References 124 6 Modeling Chronic Hepatitis C During Rapid Therapeutic Advance: Cost-Effective Screening, Monitoring, and Treatment Strategies 129Shan Liu 6.1 Introduction 129 6.2 Method 131 6.2.1 Modeling Disease Natural History and Intervention 132 6.2.2 Estimating Parameters for Disease Progression and Death 134 6.3 Four Research Areas in Designing Effective HCV Interventions 139 6.3.1 Cost-Effective Screening and Treatment Strategies 139 6.3.2 Cost-Effective Monitoring Guidelines 141 6.3.3 O ptimal Treatment Adoption Decisions 141 6.3.4 O ptimal Treatment Delivery in Integrated Healthcare Systems 145 6.4 Concluding Remarks 148 References 148 PART 2 NONCOMMUNICABLE DISEASE PREVENTION 153 7 Modeling Disease Progression and Risk-Differentiated Screening for Cervical Cancer Prevention 155Adriana Ley-Chavez and Julia L. Higle 7.1 Introduction 155 7.2 Literature Review 157 7.3 Modeling Cervical Cancer Screening 159 7.3.1 Model Components 160 7.3.2 Parameter Selection 166 7.3.3 Implementation 169 7.4 Model-Based Analyses 171 7.4.1 Cost-Effectiveness Analysis 171 7.4.2 Sensitivity Analysis 172 7.5 Concluding Remarks 174 References 175 8 Using Finite-Horizon Markov Decision Processes for Optimizing Post-Mammography Diagnostic Decisions 183Sait Tunc, Oguzhan Alagoz, Jagpreet Chhatwal, and Elizabeth S. Burnside 8.1 Introduction 183 8.2 Model Formulations 185 8.3 Structural Properties 188 8.4 Numerical Results 193 8.5 Summary 196 Acknowledgments 196 References 197 9 Partially Observable Markov Decision Processes for Prostate Cancer Screening, Surveillance, and Treatment: A Budgeted Sampling Approximation Method 201Jingyu Zhang and Brian T. Denton 9.1 Introduction 201 9.2 Review of POMDP Models and Benchmark Algorithms 204 9.3 A POMDP Model for Prostate Cancer Screening, Surveillance, and Treatment 206 9.4 Budgeted Sampling Approximation 209 9.4.1 Lower and Upper Bounds 209 9.4.2 Summary of the Algorithm 211 9.5 Computational Experiments 213 9.5.1 Finite-Horizon Test Instances 213 9.5.2 Computational Experiments 214 9.6 Conclusions 217 References 219 10 Cost-Effectiveness Analysis of Breast Cancer Mammography Screening Policies Considering Uncertainty in Women’s Adherence 223Mahboubeh Madadi and Shengfan Zhang 10.1 Introduction 223 10.2 Model Formulation 225 10.3 Numerical Studies 231 10.4 Results 233 10.4.1 Perfect Adherence Case 233 10.4.2 General Population Adherence Case 234 10.5 Summary 236 References 237 11 An Agent-Based Model for Ideal Cardiovascular Health 241Yan Li, Nan Kong, Mark A. Lawley, and José A. Pagán 11.1 Introduction 241 11.2 Methodology 243 11.2.1 Agent-Based Modeling 243 11.2.2 Model Structure 244 11.2.3 Parameter Estimation 246 11.2.4 User Interface 248 11.2.5 Model Validation 249 11.3 Results 250 11.3.1 Simulating American Adults 250 11.4 Simulating the Medicare-Age Population and the Disease-Specific Subpopulations 252 11.5 Future Research 254 11.6 Summary 255 References 255 PART 3 TREATMENT TECHNOLOGY AND SYSTEM 259 12 Biological Planning Optimization for High-Dose-Rate Brachytherapy and its Application to Cervical Cancer Treatment 261Eva K. Lee, Fan Yuan, Alistair Templeton, Rui Yao, Krystyna Kiel, and James C.H. Chu 12.1 Introduction 261 12.2 Challenges and Objectives 263 12.3 Materials and Methods 265 12.3.1 High-Dose-Rate Brachytherapy 265 12.3.2 PET Image 266 12.3.3 Novel OR-Based Treatment-Planning Model 266 12.3.4 Computational Challenges and Solution Strategies 271 12.4 Validation and Results 273 12.5 Findings, Implementation, and Challenges 276 12.6 Impact and Significance 279 12.6.1 Quality of Care and Quality of Life for Patients 279 12.6.2 Advancing the Cancer Treatment Frontier 279 12.6.3 Advances in Operations Research Methodologies 280 Acknowledgment 281 References 281 13 Fluence Map Optimization in Intensity-Modulated Radiation Therapy Treatment Planning 285Dionne M. Aleman 13.1 Introduction 285 13.2 Treatment Plan Evaluation 288 13.2.1 Physical Dose Measures 289 13.2.2 Biological Dose Measures 291 13.3 FMO Optimization Models 292 13.3.1 O bjective Functions 293 13.3.2 Constraints 295 13.3.3 Robust Formulation 297 13.4 O ptimization Approaches 299 13.5 Conclusions 300 References 301 14 Sliding Window IMRT and VMAT Optimization 307David Craft and Tarek Halabi 14.1 Introduction 307 14.2 Two-Step IMRT Planning 309 14.3 O ne-Step IMRT Planning 310 14.3.1 O ne-Step Sliding Window Optimization 310 14.4 Volumetric Modulated ARC Therapy 313 14.5 Future Work for Radiotherapy Optimization 315 14.5.1 Custom Solver for Radiotherapy 315 14.5.2 Incorporating Additional Hardware Considerations into Sliding Window VMAT Planning 315 14.5.3 Trade-Off between Delivery Time and Plan Quality 316 14.5.4 What Do We Optimize? 316 14.6 Concluding Thoughts 317 References 318 15 Modeling the Cardiovascular Disease Prevention–Treatment Trade-Off 323George Miller 15.1 Introduction 323 15.2 Methods 325 15.2.1 Model Overview 325 15.2.2 Model Structure 327 15.2.3 Model Inputs 331 15.3 Results 334 15.3.1 Base Case 334 15.3.2 Interaction between Prevention and Treatment Spending 335 15.3.3 Impact of Discount Rate on Cost-Effectiveness 336 15.3.4 O ptimal Spending Mix 337 15.3.5 Impact of Prevention Lag on Optimal Mix 338 15.3.6 Impact of Discount Rate on Optimal Mix 340 15.3.7 Impact of Time Horizon on Optimal Mix 340 15.3.8 Impacts of Research 341 15.4 Discussion 344 Acknowledgment 346 References 346 16 Treatment Optimization for Patients with Type 2 Diabetes 349Jennifer Mason Lobo 16.1 Introduction 349 16.2 Literature Review 350 16.3 Model Formulation 353 16.3.1 Decision Epochs 354 16.3.2 States 354 16.3.3 Actions 355 16.3.4 Probabilities 355 16.3.5 Rewards 356 16.3.6 Value Function 356 16.4 Numerical Results 357 16.4.1 Model Inputs 357 16.4.2 Optimal Treatment Policies to Reduce Polypharmacy 358 16.5 Conclusions 362 References 363 17 Machine Learning for Early Detection and Treatment Outcome Prediction 367Eva K. Lee 17.1 Introduction 367 17.2 Background 369 17.3 Machine Learning with Discrete Support Vector Machine Predictive Models 372 17.3.1 Modeling of Reserved-Judgment Region for General Groups 373 17.3.2 Discriminant Analysis via Mixed-Integer Programming 374 17.3.3 Model Variations 376 17.3.4 Theoretical Properties and Computational Strategies 379 17.4 Applying Damip to Real-World Applications 380 17.4.1 Validation of Model and Computational Effort 381 17.4.2 Applications to Biological and Medical Problems 381 17.4.3 Applying DAMIP to UCI Repository of Machine Learning Databases 389 17.5 Summary and Conclusion 393 Acknowledgment 394 References 394 INDEX 401

Read more less

Book Synopsis

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisDisease-carrying ticks are found in all 50 states in the U.S. and, as their numbers rise and their ranges increase, so, too, do cases of tick-borne illnesses. Alexis Chesney, a naturopathic physician specializing in the treatment of diseases transmitted through tick bites, offers a comprehensive strategy for reducing exposure to disease-causing organisms and boosting the effectiveness of standard treatment protocols. With an overview of the tick species present in the U.S. and profiles of Lyme and other top diagnosed tick-borne diseases, including anaplasmosis and babesiosis, this guide gives concerned readers and medical professionals alike a deeper understanding of how tick populations — and associated illnesses — spread, and how to combat them naturally. In addition to covering landscape-management methods for dramatically reducing tick populations around the home, Chesney outlines prophylactic herbal tinctures that provide an additional layer of protection against tick-borne illnesses — an important strategy for those living in high-risk regions, especially in the event of an undetected bite. Chesney also provides options for treating acute tick-borne diseases, if symptoms develop, as well as herbs that can be used in combination with antibiotics to augment their efficacy.

Read more less

Book Synopsis

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisThis book has primarily been aimed at epidemiologists working with empirical data for both human and veterinary diseases. The final paragraph of this preface is probably the most important paragraph of the book, and if epidemiologists or healthcare or veterinary administrators are converted to the concept outlined in the last paragraph, then the book will have served a useful purpose: twenty-five years of epidemiological research culminated in the concept described in this paragraph. This book introduces second generation epidemiological modelling. Second generation modelling uses directly measurable biomodels that do not require estimates for their quantitative values. Biomodels encompass multiple model factors that would otherwise have to be estimated, and as such biomodels are directly correlated with disease prevalence and epidemic duration. This correlation enables biomodels to accurately predict the future course of an epidemic before it unfolds, whilst concurrently directing healthcare administrators where to target manpower and financial resources for optimal disease control. Whereas first generation modelling remains a useful tool for pedagogical or teaching purposes, second generation modelling [in the form of biomodels] allows healthcare administrators to cope with the demands of immediate and rapid disease control during periods of disease epidemics. Biomodels should be developed for important infectious diseases during periods of epidemiological ''peacetime'', when manpower and resources are not held at a premium. Few non-fictional books are read cover-to-cover. To accommodate the selective reader, some of the most important concepts in this volume [such as biofactors, biomodels, subclinical disease and predictive accuracy] are repeated within relevant chapters. National and regional disease contingency planning should incorporate biomodels as useful tools when planning future disease control measures.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisFully reviewed and revised for its third edition, the Oxford Handbook of Infectious Diseases and Microbiology remains the invaluable guide to all aspects of infectious diseases and microbiology. Reflecting the current approach to joint postgraduate training programmes, the handbook takes an integrated approach to both subjects. It covers the basic principles of bacteriology and virology, along with specific guidance on individual diseases and conditions, all in the accessible Oxford Handbook style.The chapters have been expanded to include new developments that reflect the fast-changing field of infectious diseases and their managements, including novel pathogens such as SARS-CoV-2 and updated treatments for infections such as Hepatitis C. Diagnostic technologies such as whole-genome sequence based approaches are covered in greater detail, and the increased role of antimicrobial stewardship in the management of antiviral and antifungal prescribing has been substantially reviewed since the previous edition. Practical and comprehensive, this handbook includes coverage of current legislation and guidelines, as well as substantial changes to species nomenclature. Fully reviewed by specialist senior clinicians, and with useful links to up-to-date clinical information and online resources, this title remains a cornerstone for all infection trainees, those working in laboratory settings, and candidates preparing for infection examinations such as CICE and FRCPath.

Read more less

Book SynopsisThis is a history of the Rockefeller Foundation's International Health Division (1913-1951), one of the most important public health agencies of the 20th century and a precursor of the World Health Organization. The book includes descriptions of the conflicts among the "medical barons" who ran the division.Trade Review"In this endeavour it succeeds quite well. It is well researched, highly readable, and even witty at times. To be sure, the conquest of infectious disease makes for a good story and while it is easy to get lost in the names and the places, the results speak for themselves." --International Epidemiology Association "John Farley's book is a good read. Well written, generally free of opinion and jargon, and dependent largely on primary sources, it chronicles the rise and decline of the International Health Division of the Rockefeller Foundation from 1913 to 1951." --JAMA "...will render an important service to researchers..."--edical History "Overall there is much to recommend Farley's book...fill[s] this longstanding gap in the history of global public health."--Journal of the History of Medicine and Allied Sciences "In this endeavour it succeeds quite well. It is well researched, highly readable, and even witty at times. To be sure, the conquest of infectious disease makes for a good story and while it is easy to get lost in the names and the places, the results speak for themselves." --International Epidemiology Association "John Farley's book is a good read. Well written, generally free of opinion and jargon, and dependent largely on primary sources, it chronicles the rise and decline of the International Health Division of the Rockefeller Foundation from 1913 to 1951." --JAMA "...will render an important service to researchers..."--Medical History "Overall there is much to recommend Farley's book...fill[s] this longstanding gap in the history of global public health."--Journal of the History of Medicine and Allied SciencesTable of Contents1. Introduction ; PART I: ROSE'S VISION ; 2. The First Stage: Rose's Vision ; 3. Rose's Vision: Tuberculosis in France (1917-1924) ; PART II: DISEASE ERADICATION ; 4. The First Hookworm Campaigns (1913-1920) ; 5. Retreat from Hookworm (1920-1930) ; 6. Yellow Fever: From Coast to Jungle ; 7. Malaria: Killing Mosquitoes and Anophilines (1915-1935) ; 8. World War II: DDT, Typhus, and Malaria ; 9. Malaria: The Ultimate Kill ; PART III: A RESEARCH PROGRAM ; 10. Reorganization and Research Laboratories (1928-1940) ; 11. Yellow Fever Vaccines: A Slap in the Face ; 12. Disease for Research ; PART IV: TRAINING THE EXPERTS ; 13. Frustrations in Sao Paulo: The Wrong Step in Rio ; 14. Northern Lights: London and Toronto ; 15. Rough Seas: Prague, Rome, Tokyo ; PART V: FINALE ; 16. Post-War Confusion: What To Do Next? ; 17. Conclusion: Swinging Pendulums

Read more less

Book SynopsisDisease screening and disease surveillance (DSDS) constitute two critical areas in public health, each presenting distinctive challenges primarily due to their sequential decision-making nature and complex data structures. Statistical Methods for Dynamic Disease Screening and Spatio-Temporal Disease Surveillance explores numerous recent analytic methodologies that enhance traditional techniques. The author, a prominent researcher specializing in innovative sequential decision-making techniques, demonstrates how these novel methods effectively address the challenges of DSDS.After a concise introduction that lays the groundwork for comprehending the challenges inherent in DSDS, the book delves into fundamental statistical concepts and methods relevant to DSDS. This includes exploration of statistical process control (SPC) charts specifically crafted for sequential decision-making purposes. The subsequent chapters systematically outline recent advancements in dynamic scre

Read more less

Book SynopsisDr Taylor's book analyses the disease concept as it developed in medical history and seeks to clarify it with the help of concepts largely derived from logical class theories. A solution is proposed to the problem of how to distinguish between the class of 'patients' and the class of 'healthy persons' which corresponds to the actual diagnostic practices of doctors. The earliest theories of disease postulated concrete entities which exist independently of the body. The notion of disease entity has lost its original ontological connotations and instead its important feature has become the possession of a unitary and self-contained character. Dr Taylor describes the modern theories as essentially 'reactive' in character, that is the symptoms of a disease are the bodily reactions to the 'noxae'. After seeing the subject in its historical content, Dr Taylor goes on to discuss in detail the notion of the classification of diseases, making extensive use of modern views on the logic of classesTable of ContentsAcknowledgements; 1. Early notions of disease; 2. Ontological theories of disease; 3. Reactive theories of disease; 4. Source indicators and their perception; 5. Classes and classifications; 6. Morbidity; 7. Morbi; 8. Molecular morbi; 9. Summary; References; Name index; Subject index.

Read more less

Book Synopsis

Read more less

Book SynopsisIs your diet feeding or defeating disease?We are at a turning point in our understanding of how to prevent and fight disease. Rates of cancer, heart disease, strokes, diabetes, obesity and other common health problems are skyrocketing. However, the latest scientific research and clinical evidence is revealing that the power to protect ourselves against these threats and resist them lies in a simple solution: the foods we eat everyday. In Eat to Beat Disease, Dr William Li explains that your body was designed to fight threats like these and we have radically underestimated how food can be used to amplify this hidden power. Your body has five natural defence systems that, if functioning well, can protect you: angiogenesis (growing new blood vessels), cell regeneration, the microbiome, DNA protection and immunity. The healthy working of each has been found to be intimately connected to the foods we eat – and the findings are sometimes surprising. Discover: · Why scientists think drinking hot cocoa boosts stem cells crucial for your body's regeneration· The role of cheese and wine in maintaining healthy gut bacteria· Why drinking coffee lowers your risk of dyingRevealing more than 200 foods that you can incorporate into your life today to help you live longer, Dr William Li proposes a simple 5 x 5 x 5 framework, inviting you to choose five foods and eat them five times a day, to fortify your five defence systems. It is not about dieting or cutting out – it is about having the confidence to incorporate the healthy foods you already love into a plan for life-long change. It could save your life.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisGrowing public awareness of environmental hazards has led to an increased demand for public health authorities to investigate geographical clustering of diseases.Trade Review"offers the reader a new insight to the area of disease mapping" (Statistical Methods in Medical Research, Vol.10, No.6, 2001) "...Overall this book is very readable..." (Biometrics, September 2002) "...this book successfully gives comprehensive coverage of an active area of research and development...an excellent introductory text..." (Statistical Methods in Medical Research, Vol.12, No.1, 2003)Table of ContentsIntroduction. Visual Perception and Map Construction. Data Types and Sources. Basic Methods. Study Design. Advanced Methods. Public Health Surveillance and Mapping. Appendix: Software for Disease Mapping. Glossary. Index.

Read more less

Book SynopsisEmerging Infectious Diseases Emerging Infectious Diseases offers an introduction to emerging and reemerging infectious disease, focusing on significant illnesses found in various regions of the world. Many of these diseases strike tropical regions or developing countries with particular virulence, others are found in temperate or developed areas, and still other microbes and infections are more indiscriminate. This volume includes information on the underlying mechanisms of microbial emergence, the technology used to detect them, and the strategies available to contain them. The author describes the diseases and their causative agents that are major factors in the health of populations the world over. The book contains up-to-date selections from infectious disease journals as well as information from the Centers for Disease Control and Prevention, the World Health Organization, MedLine Plus, and the American Society for Microbiology. Perfect for studenTable of ContentsTables and Figures vii Preface xv The Author xvii Acknowledgments xviii Part 1: Introduction to Emerging Infectious Diseases Chapter 1: Infectious Diseases Past and Present 3 Major Concepts 4 • History of Infectious Diseases 5 • The Role of Infectious Diseases in the World Today 8 • The Links Between Infectious Diseases, Poverty, and Civil Unrest 10 • Emerging and Reemerging Infectious Diseases 12 • Factors Contributing to the Emergence of New Infectious Diseases and the Spread and Evolution of Older Diseases 15 • Timeline 18 Chapter 2: Of Microbes and Men 27 Major Concepts 28 • Introduction 30 • Infectious Agents: The Enemy Combatants 30 • Genetic Information and the Making of Proteins: Preparing the Armament 36 • The Immune Response: Humans Fight Back, Part One 40 • Antimicrobial Agents: Humans Fight Back, Part Two 46 Part 2: Bacterial Infections Chapter 3: Lyme Disease 55 Major Concepts 56 • Introduction 58 • History 60 • The Disease 61 • The Causative Agent 63 • The Immune Response 66 • Diagnosis 67 • Treatment 68 • Prevention 69 • Surveillance 71 Chapter 4: Human Ehrlichiosis 75 Major Concepts 76 • Introduction 77 • History 78 • The Diseases 79 • The Causative Agents 88 • The Immune Response 89 • Diagnosis 90 • Treatment 91 • Prevention 92 • Surveillance 92 Chapter 5: Bartonella Infections 97 Major Concepts 98 • Introduction 99 • History 99 • The Diseases 101 • The Causative Agents 106 • The Immune Response 109 • Diagnosis 110 • Treatment 111 • Prevention 111 • Surveillance 112 Chapter 6: Group A Streptococci 117 Major Concepts 118 • Introduction 119 • History 120 • The Diseases 121 • The Causative Agents 127 • The Immune Response 131 • Diagnosis 132 • Treatment 133 • Prevention 134 • Surveillance 135 Chapter 7: Escherichia coli O157:H7 139 Major Concepts 140 • Introduction 141 • History 142 • The Diseases 143 • The Causative Agents 145 • The Immune Response 151 • Diagnosis 152 • Treatment 153 • Prevention 153 • Surveillance 155 Chapter 8: Helicobacter pylori, Ulcers, and Cancer 161 Major Concepts 162 • Introduction 163 • History 164 • The Diseases 165 • The Causative Agent 168 • The Immune Response 171 • Diagnosis 172 • Treatment 173 • Prevention 174 • Surveillance 175 Chapter 9: Legionnaires’ Disease and Pontiac Fever 181 Major Concepts 182 • Introduction 183 • History 184 • The Diseases 185 • The Causative Agent 186 • The Immune Response 191 • Diagnosis 194 • Treatment 197 • Prevention 197 • Surveillance 199 Chapter 10: Pulmonary Tuberculosis and Multidrug Resistance 205 Major Concepts 206 • Introduction 207 • History 208 • The Disease 209 • The Causative Agents 212 • The Immune Response 213 • Detection and Diagnosis 214 • Treatment and Drug Resistance 216 • Prevention 219 • Surveillance 220 Chapter 11: Emerging Bacterial Drug Resistance 225 Major Concepts 226 • Introduction 227 • History 228 • The Diseases, Causative Agents, and Treatment Options 229 • Mechanisms of Resistance 235 • Diagnosis 239 • Prevention 240 • Surveillance 240 Part 3: Viral Infections Chapter 12: Marburg and Ebola Hemorrhagic Fevers 247 Major Concepts 248 • Introduction 249 • History 250 • The Diseases 254 • The Causative Agents 257 • The Immune Response 262 • Diagnosis 263 • Treatment 264 • Prevention 264 • Surveillance 267 Chapter 13: American Hemorrhagic Fevers 273 Major Concepts 274 • Introduction 275 • History 277 • The Diseases 278 • The Causative Agents 282 • The Immune Response 285 • Diagnosis 286 • Treatment 287 • Prevention 287 • Surveillance 288 Chapter 14: Lassa Hemorrhagic Fever 293 Major Concepts 294 • Introduction 295 • History 296 • The Disease 298 • The Causative Agent 300 • The Immune Response 303 • Diagnosis 304 • Treatment 304 • Prevention 306 • Surveillance 308 Chapter 15: Dengue Fever and Dengue Hemorrhagic Fever 313 Major Concepts 314 • Introduction 315 • History 316 • The Diseases 318 • The Causative Agent 321 • The Immune Response 324 • Diagnosis 327 • Treatment 327 • Prevention 328 • Surveillance 329 Chapter 16: The Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome 335 Major Concepts 336 • Introduction 338 • History 339 • The Diseases 341 • The Causative Agent 344 • The Immune Response 350 • Diagnosis and Detection 355 • Treatment 355 • Prevention 357 • Surveillance 358 Chapter 17: Human Herpesvirus 8 and Kaposi’s Sarcoma 365 Major Concepts 366 • Introduction 367 • History 368 • The Diseases 368 • The Causative Agent 373 • The Immune Response 378 • Diagnosis 379 • Treatment 380 • Prevention 383 • Surveillance 383 Chapter 18: Hepatitis C 389 Major Concepts 390 • Introduction 391 • History 392 • The Diseases 392 • The Causative Agent 397 • The Immune Response 399 • Diagnosis 401 • Treatment 402 • Prevention 403 • Surveillance 404 Chapter 19: Epidemic and Pandemic Influenza 409 Major Concepts 410 • Introduction 411 • History 412 • The Disease 414 • The Causative Agent 415 • The Immune Response 421 • Diagnosis 421 • Treatment 422 • Prevention 422 • Surveillance 425 Chapter 20: Hantavirus Pulmonary Syndrome 431 Major Concepts 432 • Introduction 433 • History 435 • The Diseases 435 • The Causative Agents 439 • The Immune Response 444 • Diagnosis 445 • Treatment 446 • Prevention 447 • Surveillance 450 Chapter 21: Severe Acute Respiratory Syndrome 455 Major Concepts 456 • Introduction 457 • History 457 • The Disease 460 • The Causative Agent 461 • The Immune Response 464 • Diagnosis 465 • Treatment 466 • Prevention 467 • Surveillance 469 Chapter 22: West Nile Disease in the United States 475 Major Concepts 476 • Introduction 477 • History 477 • The Diseases 481 • The Causative Agent 484 • The Immune Response 487 • Diagnosis 488 • Treatment 489 • Prevention 490 • Surveillance 493 Chapter 23: Monkeypox 499 Major Concepts 500 • Introduction 501 • History 502 • The Disease 505 • The Causative Agent 508 • The Immune Response 511 • Diagnosis 513 • Treatment 514 • Prevention 514 • Surveillance 516 Part 4: Parasitic Infections Chapter 24: Malaria: Reemergence and Recent Successes 523 Major Concepts 524 • Introduction 526 • History 526 • The Disease 528 • The Causative Agents 529 • The Immune Response 533 • Diagnosis 535 • Treatment and Drug Resistance 535 • Prevention: Failures and Successes 537 • Surveillance 541 Chapter 25: Babesiosis 547 Major Concepts 548 • Introduction 549 • History 549 • The Disease 550• The Causative Agent 553 • The Immune Response 557 • Diagnosis 558 • Treatment 558 • Prevention 560 • Surveillance 560 Chapter 26: Cryptosporidiosis 565 Major Concepts 566 • Introduction 567 • History 568 • The Disease 569 • The Causative Agents 570 • The Immune Response 576 • Diagnosis 577 • Treatment 578 • Prevention 580 • Surveillance 581 Chapter 27: Chagas’ Disease and Its Emergence in the United States 585 Major Concepts 586 • Introduction 587 • History 587 • The Disease 588 • The Causative Agent 591 • The Immune Response 595 • Diagnosis 598 • Treatment 599 • Prevention 600 • Surveillance 601 Part 5: Infectious Proteins Chapter 28: Creutzfeldt-Jakob Disease and Other Transmissible Spongiform Encephalopathies 609 Major Concepts 610 • Introduction 611 • History 612 • The Diseases 613 • The Causative Agents 621 • The Immune Response 625 • Diagnosis 626 • Treatment 627 • Prevention 628 • Surveillance 628 Part 6: Special Issues in Infectious Diseases Chapter 29: The Emerging Importance of Infectious Diseases in the Immunosuppressed 635 Major Concepts 636 • Introduction 637 • Immunosuppressed Populations 637 • Selected Causes of Immunosuppression 638 • Infectious Diseases of the Immunosuppressed 642 Chapter 30: The Emerging Threat of Bioweapons 667 Major Concepts 668 • Introduction 669 • History 670 • Bioterrorism Agents and Diseases 671 • The Threat of Agroterrorism 692 • Preparation for Biological Attacks 693 • Protective Vaccines 694 Glossary 701 Index 723

Read more less

Book SynopsisTable of Contents1. From the Origin of Disease to Pandemic Infectious Diseases2. The Age of Chronic and Late Chronic Diseases: A New View of Diseases3. Five Strategies of Our Body to Fight Disease4. Method of Ending Disease and the Future Medical System5. After the End of Disease

Read more less

Book SynopsisThe Third Edition of Health Promotion and Disease Prevention in Clinical Practice reflects a clinically-focused, team-based approach to health promotion conversations. This practical reference incorporates the latest guidelines from major organizations, including the U.S. Preventive Services Task Force, and offers a complete overview of how to help patients adopt healthy behaviors and deliver recommended screening tests and immunizations. Packed with realistic strategies throughout, it offers expert guidance on counseling patients about exercise, nutrition, tobacco use, substance use, sexually transmitted infections, depression, and more. Provides sample conversations and practical strategies for preventive counseling during each stage of the patient encounter: gathering information from the patient, ordering evidence-based screenings and lab tests, designing personalized health maintenance plans, facilitating behavior change, and more. Incorporates real-wor

Read more less

Book SynopsisMotivated by business pressures, market consolidation, and the pursuit of quality care, health care professionals in all areas of practice are beginning to explore more fully the tremendous potential of disease management-- a systemwide strategy for proactively managing chronic diseases across the entire continuum of care. Disease Management is the first book to bring together systems thinking and organizational structure in a framework for designing, developing, and implementing a comprehensive health management system.

Read more less

Book SynopsisTable of ContentsPreface ix Acknowledgements x Abbreviations xi Glossary of terms used in this book xii About the companion website xxiii 1 Introduction to lifespan nutrition 1 1.1 The lifespan approach to nutrition 1 1.2 The concept of balance 2 1.2.1 A supply and demand model 2 1.2.2 Overnutrition 3 1.2.3 Undernutrition 4 1.2.3.1 Increased demand 4 1.2.3.2 The metabolic response to trauma 4 1.2.3.3 Compromised supply and deficiency 6 1.2.3.4 Malnutrition 7 1.2.4 Classical balance studies 11 1.2.5 Overall nutritional status 12 1.3 The individual response to nutrition 12 1.3.1 Stage of the lifespan 13 1.3.2 Genetics 14 1.4 Personalized nutrition 17 1.5 Assessment of nutritional status 19 1.5.1 Anthropometric measures 19 1.5.2 Estimating dietary intakes 20 1.5.2.1 Indirect measures 20 1.5.2.2 Direct measures 21 1.5.3 Biomarkers of nutritional status 24 1.5.4 Clinical examination 25 1.6 Nutritional epidemiology: understanding diet–disease relationships 26 1.6.1 The importance of the evidence base 26 1.6.2 Nutritional epidemiology 26 1.6.3 Cause and effect 27 1.6.4 Bias and confounding 27 1.6.5 Quantifying the relationship between diet and disease 28 1.6.6 Study designs in nutritional epidemiology 29 1.6.6.1 Ecological studies 31 1.6.6.2 Cross‐sectional studies 32 1.6.6.3 Case–control studies 33 1.6.6.4 Cohort studies 33 1.6.6.5 Randomized controlled trials 33 1.6.6.6 Systematic review and metaanalysis 34 1.6.6.7 Scoping reviews 34 1.7 Dietary reference values 35 1.7.1 The UK dietary reference values system 36 1.7.2 Dietary reference values in other countries 39 2 Before life begins 45 2.1 Introduction 45 2.2 Nutrition and female fertility 46 2.2.1 Determinants of fertility and infertility 46 2.2.1.1 The endocrine control of female reproduction 47 2.2.1.2 Disordered reproductive cycling 48 2.2.1.3 Polycystic ovary syndrome 48 2.2.2 Importance of body fat 50 2.2.3 Role of leptin 51 2.2.4 Antioxidant nutrients 53 2.2.5 Caffeine and alcohol 55 2.3 Nutrition and male fertility 56 2.3.1 Determinants of fertility and infertility 56 2.3.2 Obesity 60 2.3.3 Alcohol 61 2.3.4 Zinc 61 2.3.5 Antioxidant nutrients 62 2.3.6 Selenium 63 2.3.7 Phytoestrogens and environmental oestrogens 63 2.3.7.1 Phthalates 64 2.3.7.2 Phytoestrogens 64 2.3.7.3 Pesticides 65 2.4 Preparation for pregnancy 66 2.4.1 Why prepare for pregnancy? 66 2.4.2 Maternal weight management 66 2.4.3 Vitamin A and liver 66 2.4.4 Folic acid and neural tube defects 69 2.4.4.1 Supplementation with folic acid 71 2.4.4.2 Fortification with folic acid 71 3 Pregnancy 79 3.1 Introduction 79 3.2 Physiological demands of pregnancy 81 3.2.1 Maternal weight gain and body composition changes 81 3.2.2 Blood volume expansion and cardiovascular changes 82 3.2.3 Renal changes 83 3.2.4 Respiratory changes 83 3.2.5 Gastrointestinal changes 84 3.2.6 Metabolic adaptations 84 3.3 Nutrient requirements in pregnancy 85 3.3.1 Energy protein and lipids 85 3.3.2 Micronutrients 87 3.3.2.1 Iron 87 3.3.2.2 Calcium and other minerals 89 3.3.2.3 Vitamin D 90 3.4 Diet in relation to pregnancy outcomes 91 3.4.1 Miscarriage and stillbirth 91 3.4.2 Premature labour 92 3.4.2.1 Prepregnancy body mass index and pregnancy weight gain 92 3.4.2.2 Alcohol and caffeine consumption 94 3.4.2.3 Oral health 96 3.4.3 Hypertensive disorders of pregnancy 97 3.4.3.1 The aetiology of pre‐eclampsia 98 3.4.3.2 Nutrition‐related factors and pre‐eclampsia 99 3.4.4 Abnormal labour 101 3.5 Nausea and vomiting of pregnancy 102 3.5.1 Nausea and vomiting of pregnancy as a normal physiological process 102 3.5.2 Hyperemesis gravidarum 104 3.6 Cravings and aversions 106 3.6.1 Pica 107 3.7 Gastrointestinal disturbances in pregnancy 108 3.8 High‐risk pregnancies 108 3.8.1 Gestational diabetes 108 3.8.2 Adolescent and older mothers 110 3.8.3 Multiple pregnancies 111 3.8.4 Fetal alcohol spectrum disorders 113 4 Fetal nutrition and disease in later life 123 4.1 Introduction 123 4.2 The developmental origins of adult disease 123 4.2.1 The concept of programming 123 4.2.2 Fetal programming and human disease 125 4.2.2.1 Fetal growth 125 4.2.2.2 Nutrition and the constraint of growth 126 4.2.2.3 Fetal growth health and disease 127 4.3 Evidence linking maternal nutrition to disease in later life 129 4.3.1 Epidemiology 129 4.3.1.1 Association of disease with birth anthropometry 129 4.3.1.2 Maternal nutrition and later disease 131 4.3.1.3 Maternal obesity and later disease 132 4.3.2 Criticisms of the programming hypothesis 133 4.3.3 Experimental studies 134 4.3.3.1 Global undernutrition 136 4.3.3.2 Micronutrients 136 4.3.3.3 Macronutrients 137 4.4 Mechanistic basis of fetal programming 138 4.4.1 Thrifty phenotypes and genotypes 138 4.4.2 Mismatched environments 139 4.4.3 Tissue remodelling 139 4.4.4 Endocrine imbalance 141 4.4.5 Nutrient–gene interactions 144 4.4.5.1 Polymorphisms in humans 144 4.4.5.2 Gene expression in animals 145 4.4.6 Epigenetic regulation 145 4.5 Implications of the developmental origins hypothesis 148 4.5.1 Public health interventions 148 4.5.2 Transgenerational transmission of disease risk 149 5 Lactation and infant feeding 157 5.1 Introduction 157 5.2 The physiology of lactation 157 5.2.1 Anatomy of the breast 157 5.2.1.1 The nipple and areola 157 5.2.1.2 The lactiferous ducts 158 5.2.1.3 The lactiferous sinuses 158 5.2.1.4 The alveolar cells 158 5.2.1.5 The rooting reflex 158 5.2.2 Synthesis of milk 158 5.2.2.1 Foremilk and hindmilk 159 5.2.2.2 Time of day 159 5.2.2.3 Course of lactation 160 5.2.2.4 Synthesis of carbohydrates 160 5.2.2.5 Origins of milk fats 160 5.2.2.6 Milk proteins 161 5.2.3 Endocrine control of lactation 162 5.2.3.1 The breast during pregnancy 162 5.2.3.2 Established lactation 162 5.2.3.3 The breast after weaning 163 5.2.4 Maintenance of lactation 164 5.2.5 Nutritional demands of lactation 164 5.3 The advantages of breastfeeding 165 5.3.1 Advantages for the mother 165 5.3.1.1 Convenience and cost 165 5.3.1.2 Bond with infant 166 5.3.1.3 Recovery from pregnancy 166 5.3.1.4 Long‐term health 167 5.3.2 Advantages for the infant 168 5.3.2.1 Immunoprotection 168 5.3.2.2 Sudden infant death 169 5.3.2.3 Cognitive development 169 5.3.2.4 Obesity 171 5.3.2.5 Atopy 171 5.3.2.6 Milk contaminants 172 5.3.3 Recommendation to breastfeed for six months 173 5.4 Trends in breastfeeding behaviour 174 5.4.1 Reasons why women do not breastfeed 176 5.4.1.1 Cultural factors 176 5.4.1.2 Technique infection and stress 177 5.4.2 Promoting breastfeeding 178 5.5 Situations in which breastfeeding is not advised 179 5.6 Alternatives to breastfeeding 181 5.6.1 Cow’s milk formulas 182 5.6.1.1 Milk stages and follow‐on milk 183 5.6.2 Preterm formulas 184 5.6.3 Soy formulas 185 5.6.4 Hydrolysed protein and amino acid‐based formulas 185 5.6.5 Other formulas 185 6 Nutrition and childhood 191 6.1 Introduction 191 6.2 Infancy (birth to five) 192 6.2.1 The key developmental milestones 192 6.2.2 Nutrient requirements 193 6.2.2.1 Macronutrients and energy 193 6.2.2.2 Micronutrients 196 6.2.3 Nutrient intakes and infants 197 6.2.4 Transition to an adult pattern of food intake 198 6.2.4.1 Complementary feeding 198 6.2.4.2 Nutrition‐related problems 201 6.2.4.3 Barriers to healthy nutrition 206 6.3 Childhood (5–13) 212 6.3.1 Nutrient requirements of the older child 212 6.3.2 School meals and the promotion of healthy eating 213 6.3.3 The importance of breakfast 214 6.4 Obesity in children 215 6.4.1 The rising prevalence of obesity 215 6.4.2 The causes of obesity in childhood 217 6.4.2.1 Physical activity 217 6.4.2.2 Food intake 218 6.4.2.3 Genetic disorders 221 6.4.3 The consequences of childhood obesity 222 6.4.3.1 Immediate health consequences 222 6.4.3.2 Tracking of obesity: consequences for the future 222 6.4.4 Treatment of childhood obesity 224 6.4.5 Prevention of childhood obesity 226 7 Nutrition and adolescence 237 7.1 Introduction 237 7.2 Physical development 237 7.2.1 Growth rate 237 7.2.2 Body composition 238 7.2.3 Puberty and sexual maturation 239 7.2.4 Bone growth 241 7.3 Psychosocial development 244 7.4 Nutritional requirements in adolescence 245 7.4.1 Macronutrients and energy 245 7.4.2 Micronutrients 246 7.5 Nutritional intakes in adolescence 247 7.5.1 Factors that influence food choice 248 7.5.2 Food consumed out of the home 249 7.5.3 Meal skipping and snacking 250 7.6 Potential problems with nutrition 251 7.6.1 Dieting and weight control 251 7.6.2 The teenage vegetarian 253 7.6.3 Sport and physical activity 254 7.6.4 Eating disorders 255 7.6.4.1 Anorexia nervosa 256 7.6.4.2 Bulimia nervosa 257 7.6.5 The pregnant teenager 258 7.6.6 The transgender teenager 260 7.6.7 Alcohol 262 7.6.8 Tobacco smoking 264 7.6.9 Drug abuse 266 8 The adult years 274 8.1 Introduction 274 8.2 Changing needs for nutrients 274 8.3 Guidelines for healthy nutrition 276 8.4 Disease states associated with unhealthy nutrition and lifestyle 279 8.4.1 Obesity 279 8.4.1.1 Classification of overweight and obesity 279 8.4.1.2 Prevalence and trends in obesity 280 8.4.1.3 Causes of obesity in adulthood 281 8.4.1.4 Treatment of obesity 281 8.4.2 Type 2 diabetes 284 8.4.3 The metabolic syndrome 287 8.4.4 Cardiovascular disease 288 8.4.4.1 What is cardiovascular disease? 288 8.4.4.2 Risk factors for cardiovascular disease 290 8.4.4.3 Nutrition‐related factors and risk of cardiovascular disease 291 8.4.5 Cancer 302 8.4.5.1 What is cancer? 302 8.4.5.2 Diet is a modifiable determinant of cancer risk 303 8.4.5.3 Nutritional epidemiology and cancer 305 8.4.5.4 Dietary factors that may promote cancer 309 8.4.5.5 Dietary factors that may reduce cancer risk 316 9 Nutrition ageing and older adults 330 9.1 Introduction 330 9.2 The ageing population 330 9.3 The ageing process 331 9.3.1 Impact on physiological systems 331 9.3.2 Mechanisms of cellular senescence 332 9.3.2.1 Oxidative senescence 332 9.3.2.2 The role of p53 activation 334 9.3.2.3 Telomere shortening 334 9.3.2.4 The Ink4a/ARF axis 335 9.3.3 Nutritional modulation of the ageing process 336 9.3.3.1 Caloric restriction and lifespan 336 9.3.3.2 Fetal programming of lifespan 338 9.3.3.3 Supplementary antioxidants 338 9.4 Nutrient requirements of the elderly 339 9.4.1 Macronutrients and energy 339 9.4.2 Micronutrients 339 9.4.3 Specific guidelines for the elderly 339 9.5 Barriers to healthy nutrition in the elderly 340 9.5.1 Malnutrition and the elderly 340 9.5.2 Poverty 341 9.5.3 Social isolation 342 9.5.4 Education 342 9.5.5 Physical changes 343 9.5.6 Combating malnutrition in the elderly 343 9.6 Common nutrition‐related health problems 345 9.6.1 Bone disorders 345 9.6.1.1 Bone mineralization and remodelling 345 9.6.1.2 Osteoporosis pathology and prevalence 346 9.6.1.3 Risk factors for osteoporosis 347 9.6.1.4 Dietary interventions for osteoporosis prevention 347 9.6.1.5 Paget’s disease of bone 350 9.6.2 Immunity and infection 350 9.6.3 Digestive tract disorders 354 9.6.3.1 Mouth and oesophagus 354 9.6.3.2 Stomach 354 9.6.3.3 Small intestine 354 9.6.3.4 Large intestine 354 9.6.4 Anaemia 355 9.6.4.1 Iron deficiency anaemia 357 9.6.4.2 Vitamin B12 deficiency 357 9.6.4.3 Folate deficiency 358 9.6.4.4 Cognitive impairment and anaemia 359 Appendix An introduction to the nutrients 368 Index 379

Read more less

Book SynopsisResearchers are still identifying micro-organisms that cause new diseases in humans. A basic factor in the emergence of these diseases is the role played by animals, which act as a reservoir for certain viruses. In favourable conditions, such viruses can cross the species barrier and infect humans. The book takes a close look at two families of virus: orthomyxoviridae and paramyxoviridae, which have infected many species of vertebrates and are responsible for zoonosis. The two main parts of the book describe how the viruses operate, how they spread and the risk factors for humans. In addition to a specific and detailed study of these two micro-organisms, the book highlights the fascinating history of such diseases, their emergence, development and disappearance. They have occurred throughout human history, underscoring the role of the environment and the way it changes, often as a result of human intervention. Sponsored by the Mérieux Foundation and written by leading international specialists, this book provides first-class information about these new viruses.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisLyme disease remains a subject of considerable public and clinical interest and misunderstandings about Lyme borreliosis continue to cause widespread concern about potential long-term disability.Although the infection occurs primarily in highly endemic areas of Europe and North America, these areas are expanding, as global warming leads to a steady expansion of the tick vectors' habitats.In the period since the 2nd edition was published our understanding of the biology, clinical manifestations, diagnosis and treatment of this infection have continued to evolve. Many of these important advances have been clarified in a new US joint clinical guideline by the Infectious Diseases Society of America, American Academy of Neurology and American College of Rheumatology.The new edition of the book also:?Updates knowledge of the reservoir hosts, competent vectors and the necessary vector-human interactions required to make infection possible.?Explains new approaches that improve accurate laboratory diagnosis.?Elaborates on the clinical manifestations that may or may not be indicative of infection.?Updates treatment recommendations.?Considers multiple dimensions of symptoms occurring in patients who have had Lyme disease.This volume is intended for all medical practitioners who will need to consider this infection in the differential diagnosis of the patients they treat. Alongside an overview of the disease and its pathology, focused chapters explain the cutaneous, rheumatologic and neurologic manifestations.The book further emphasizes how to differentiate between neurobehavioral symptoms commonly misattributed to Lyme neuroborreliosis and disorders actually associated with nervous system infection - a differentiation informed by considerable new data in recent years.

Read more less

Book SynopsisPathogenic microorganisms exploit a number of different routes for transmission and this book demonstrates how the spread of disease can be prevented through the practices of disinfection and controlling microbial growth.Trade ReviewReview of the hardback: ' … well written, and each chapter is extensively referenced'. The Journal of Medical MicrobiologyTable of ContentsPreface; 1. The transmission and prevention of disease C. J. Hurst and P. A. Murphy; 2. Strategies for modeling microbial colonization of the human body in health and disease R. A. Ross and M T Lee; 3. Role of pathogen monitoring in microbial risk assessment J. B. Rose, J. T. Lisle and C. N. Haas; 4. Estimating the risk of acquiring infectious disease from ingestion of water C. J. Hurst, R. M. Clark and S. E. Regli; 5. Bacterial resistance to potable water disinfectants M. H. Stewart and B. H. Olson; 6. Preventing foodborne infectious disease C. J. Hurst; 7. Disinfection of microbial aerosols S. Clark and P. Scarpino; 8. Transmission of viral infections through animate and inanimate surfaces and infection control through chemical disinfection S. A. Sattar and V. S. Springthorpe; 9. The role of chemical disinfectants in controlling bacterial contaminants on environmental surfaces D. J. Gaber, T. M. Cusack and E. Scott; 10. Sterilization and disinfection of medical devices A. B. Margolin and V. C. Chamberlain; 11. Ultraviolet light disinfection of water and wastewater P. F. Roessler and B. F. Severin; 12. Thermal inactivation of microorganisms G. Le Jean and G. Abraham; Index.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisGet ready to provide efficient, informed patient care, with the newly updated Professional Guide to Diseases , 11th Edition . This comprehensive guide offers the causes, signs and symptoms for more than 600 disorders, with expert nursing direction on tests, assessments, diagnosis, treatments, and special considerations.Whether you are a student preparing for board certification or are a new or experienced nurse, this is vital support for understanding correct treatment of the common conditions seen almost daily. Build up your ground-floor knowledge of a wide range of common disorders and diseases: NEW full-color figures and illustrations Boxed text on pathophysiology and prevention that helps reinforce difficult concepts Icons that emphasize important concepts: Elderly Tip, Pediatric Tip, Clinical Alert, Life-Threatening Disorder, and Confirming Diagnosis Consistent template that makes information quick and easy to find yet comprehensive enough to offer complete coverage of a group of similar diseases Expert guidance that leads you to targeted, cost-effective testing Chapters offer a thorough grounding in:Disorders found in individual body systems – Cardiovascular; respiratory; neurologic; gastrointestinal; hepatobiliary; musculoskeletal; renal and urologic; immune; hematologic; metabolic and nutritional; endocrine; eye; ear, nose and throat; skin; genetic; obstetric and gynecologic; sexual; and psychiatric Malignant neoplasms – Head, neck and spine; thorax; abdomen and pelvis; male and female genitalia; bone, skin and soft tissue; blood and lymph Infection – Gram-positive cocci, gram-negative cocci, gram-positive bacilli, gram-negative bacilli, spirochetes and mycobacteria, mycoses, respiratory viruses, rash-producing viruses, enteroviruses, arbovirus, miscellaneous viruses, rickettsia, protozoa, helminths Trauma – Head, neck and spine, thorax, abdomen, extremities, whole body Updated information on rare diseases, potential agents of bioterrorism, and complementary and alternative therapies for specific conditions, with additional coverage for more than 50 life-threatening disorders Detailed guidance on hundreds of commonly seen disorders and diseases in easy-to-read language — ideal for both graduate and undergraduate study Offers new nurses the confidence to function fully while building on-the-unit skills and know-how Small enough size to carry with you as a solid resource — informative, concise and organized for easy reference Your book purchase includes a complimentary download of the enhanced eBook for iOS™, Android™, PC and Mac. Take advantage of these practical features that will improve your eBook experience: The ability to download the eBook on multiple devices at one time — providing a seamless reading experience online or offline Easily convert to audiobook, powering your content with natural language text-to-speech Powerful search tools and smart navigation cross-links that allow you to search within this book, or across your entire library of VitalSource eBooks About the Clinical Editor Dr. Laura M. Willis, DNP, APRN-CNP,CMSRN, is a Family Nurse Practitioner at Urbana Family Medicine and Pediatrics in Urbana, Ohio

Read more less

Book SynopsisThis book summarises the current state of the art of our understanding of the problem of non-communicable diseases and their primary prevention. It aims to increase international awareness of the global burden of non-communicable diseases and in particular to highlight the trends in developing countries; evaluates the impact of changes in diet, nutrition and lifestyle that predispose to chronic non-communicable diseases in modern societies; shares knowledge of the growing problems on non-communicable diseases and experiences related to its prevention between health professionals of developing and developed countries; identifies and prioritises major research issues and suggest strategies to deal with the global epidemic of chronic non-communicable diseases.Trade Review"This book represents a well organized and edited report of the Sixth Annual Public Health Forum.... Surely, [the Forum] and this book...borrowing a sentence from the preface, have 'given a significant contribution to the...acceleration of action that is required to counter and reverse...diet-related NCD.'" (European Journal of Public Health, Vol. 9, No. 1, 1999)Table of ContentsOverview of Diet-Related Non-Communicable Diseases. Prenatal Influences on Disease in Later Life. Cardiovascular Disease and Diabetes in Migrants - Interactions Between Nutritional Changes and Genetic Background. Inequalities in Diet and Health Dietary Fats and Non-Communicable Diseases. Diet and Large Bowel Cancer. Interactions Between Diet and endogenous Hormones: Possible Role in Breast Cancer Assessing the Net Effect of Alcohol Consumption on Mortality. The Public Health Impact of Globalisation of Food Trade Some Aspects of Norwegian Nutrition and Food Policy Symposium: The Burgeoning Global Burden of Obesity. Workshop Reports Diet, Lifestyle and Chronic Disease: Lessons From Contrasting Worlds. Where Do We Go From Here in Public Health? Index.

Read more less

Book SynopsisExplores the principles underlying the biological challenges, medical interventions, the continuing research agenda, and operational considerations for post-immunization strategies for vaccine-preventable viral diseases, and highlights important efforts that may facilitate wise decision making.Table of Contents1 Front Matter; 2 Summary and Assessment; 3 1 Introduction; 4 2 Major Efforts for Disease Eradication; 5 3 Biological Challenges to Post-Eradication; 6 4 Operational and Instutional Challenges to Post-Eradication; 7 5 Medical Intervention and Technological Solutions; 8 6 The Challenges to Post-Eradication Outbreaks; 9 Appendix A: Glossary and Acronyms; 10 Appendix B: Workshop Agenda; 11 Appendix C: Forum Member and Speaker Biographies

Read more less

Book SynopsisOffers an in-depth report on advanced statistical tools for public health disease surveillance, which is the result of a prestigious World Health Organisation (WHO) and EU Biomed programme initiative. Traditionally, the role of public health disease surveillance has been to identify and evaluate morbidity and mortality but increasingly, more sophisticated methods are being applied as the authorities extend their studies to include control and prevention of disease. This book brings together leading experts to discuss complex methodologies for the statistical evaluation of disease mapping and risk assessment. It includes a broad variety of statistical techniques and where appropriate, examples are included on topical issues such as the analysis of putative health hazards. For easy reference the text is presented in five distinct sections, each with an introductory review: * Disease Mapping * Clustering of Disesase * Ecological Analysis * Risk AsseTrade Review"…full of rich ideas and methods that are useful..." (Journal of Statistical Computation and Simulation, April 2005) "...sure to be an essential reference for anyone working in this area" (ISCB Newsletter, December 2000)Table of ContentsPartial table of contents: DISEASE MAPPING. Disease Mapping and Its Uses. Disease Mapping with Hidden Structures Using Mixture Models. CLUSTERING OF DISEASE. Inference for Extremes in Disease Mapping. Edge Effects in Disease Mapping. Empirical Studies of Cluster DetectionDifferent Cluster Tests in Application to German Cancer Maps. ECOLOGICAL ANALYSIS. Introduction to Spatial Models in Ecological Analysis. Multilevel Modelling of Area-Based Health Data. RISK ASSESSMENT FOR PUTATIVE SOURCES OF HAZARD. A Review of Modelling Approaches in Health Risk Assessment around Putative Sources. Lung Cancer Near Point Emission Sources. PUBLIC HEALTH APPLICATIONS AND CASE STUDIES. Environmental Epidemiology, Public Health Advocacy and Policy. The Character and the Public Health Implications of Ecological Analyses. Estimating the Presence and the Degree of Heterogeneity of Disease Rates. Ecological Regression with Errors in Covariates: An Application. Lung Cancer Mortality in Women in Germany 1995: A Case Study in Disease Mapping. Appendix. Index.

Read more less

Book SynopsisEnjoy radiant health as you learn to heal from within and reverse toxic thought patterns.

Read more less